Tompkins Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $263K | Sell |
4,558
-200
| -4% | -$11.5K | 0.02% | 177 |
|
|
2026
Q1 | $289K | Buy |
4,758
+66
| +1% | +$3.85K | 0.02% | 161 |
|
|
2025
Q4 | $253K | Sell |
4,692
-1,016
| -18% | -$48.9K | 0.02% | 175 |
|
|
2025
Q3 | $257K | Hold |
5,708
| – | – | 0.02% | 168 |
|
|
2025
Q2 | $264K | Sell |
5,708
-3,443
| -38% | -$169K | 0.02% | 159 |
|
|
2025
Q1 | $558K | Buy |
9,151
+225
| +3% | +$13.1K | 0.05% | 123 |
|
|
2024
Q4 | $505K | Sell |
8,926
-160
| -2% | -$8.94K | 0.05% | 119 |
|
|
2024
Q3 | $470K | Sell |
9,086
-1,057
| -10% | -$49.6K | 0.05% | 127 |
|
|
2024
Q2 | $421K | Sell |
10,143
-2,021
| -17% | -$90.4K | 0.04% | 141 |
|
|
2024
Q1 | $660K | Buy |
12,164
+325
| +3% | +$16.6K | 0.07% | 115 |
|
|
2023
Q4 | $607K | Buy |
11,839
+1,358
| +13% | +$71.3K | 0.07% | 115 |
|
|
2023
Q3 | $608K | Sell |
10,481
-1,167
| -10% | -$71.5K | 0.1% | 103 |
|
|
2023
Q2 | $745K | Sell |
11,648
-450
| -4% | -$30.2K | 0.12% | 98 |
|
|
2023
Q1 | $839K | Sell |
12,098
-2,977
| -20% | -$210K | 0.14% | 88 |
|
|
2022
Q4 | $1.08M | Buy |
15,075
+213
| +1% | +$16.1K | 0.17% | 81 |
|
|
2022
Q3 | $1.06M | Hold |
14,862
| – | – | 0.18% | 81 |
|
|
2022
Q2 | $1.15M | Sell |
14,862
-400
| -3% | -$30.5K | 0.18% | 79 |
|
|
2022
Q1 | $1.11M | Buy |
15,262
+4,641
| +44% | +$312K | 0.16% | 84 |
|
|
2021
Q4 | $662K | Buy |
10,621
+820
| +8% | +$48.1K | 0.12% | 85 |
|
|
2021
Q3 | $580K | Buy |
+9,801
| New | +$645K | 0.11% | 89 |
|
|
2021
Q1 | $654K | Sell |
10,356
-241
| -2% | -$15K | 0.11% | 88 |
|
|
2020
Q4 | $657K | Sell |
10,597
-1,601
| -13% | -$98.4K | 0.12% | 87 |
|
|
2020
Q3 | $735K | Sell |
12,198
-809
| -6% | -$48.7K | 0.14% | 86 |
|
|
2020
Q2 | $765K | Sell |
13,007
-530
| -4% | -$31.7K | 0.16% | 83 |
|
|
2020
Q1 | $755K | Sell |
13,537
-91
| -0.7% | -$5.56K | 0.17% | 79 |
|
|
2019
Q4 | $875K | Buy |
13,628
+9,099
| +201% | +$521K | 0.16% | 88 |
|
|
2019
Q3 | $229K | Buy |
4,529
+100
| +2% | +$4.7K | 0.05% | 148 |
|
|
2019
Q2 | $201K | Sell |
4,429
-1,208
| -21% | -$56.3K | 0.04% | 153 |
|
|
2019
Q1 | $269K | Sell |
5,637
-144
| -2% | -$7.17K | 0.05% | 146 |
|
|
2018
Q4 | $300K | Buy |
5,781
+200
| +4% | +$10.7K | 0.07% | 140 |
|
|
2018
Q3 | $347K | Sell |
5,581
-1
| -0% | -$59 | 0.07% | 140 |
|
|
2018
Q2 | $309K | Hold |
5,582
| – | – | 0.07% | 147 |
|
|
2018
Q1 | $353K | Sell |
5,582
-517
| -8% | -$33.3K | 0.08% | 139 |
|
|
2017
Q4 | $374K | Buy |
6,099
+1,146
| +23% | +$71.7K | 0.09% | 129 |
|
|
2017
Q3 | $315K | Sell |
4,953
-200
| -4% | -$11.7K | 0.07% | 136 |
|
|
2017
Q2 | $287K | Buy |
5,153
+200
| +4% | +$10.9K | 0.07% | 135 |
|
|
2017
Q1 | $270K | Sell |
4,953
-397
| -7% | -$21.8K | 0.07% | 134 |
|
|
2016
Q4 | $313K | Hold |
5,350
| – | – | 0.08% | 125 |
|
|
2016
Q3 | $288K | Sell |
5,350
-400
| -7% | -$25.7K | 0.08% | 128 |
|
|
2016
Q2 | $423K | Buy |
5,750
+967
| +20% | +$68.3K | 0.13% | 113 |
|
|
2016
Q1 | $306K | Sell |
4,783
-787
| -14% | -$49.6K | 0.1% | 130 |
|
|
2015
Q4 | $383K | Buy |
5,570
+144
| +3% | +$9.52K | 0.12% | 128 |
|
|
2015
Q3 | $321K | Sell |
5,426
-723
| -12% | -$45.9K | 0.1% | 132 |
|
|
2015
Q2 | $409K | Buy |
6,149
+219
| +4% | +$14.4K | 0.11% | 124 |
|
|
2015
Q1 | $382K | Hold |
5,930
| – | – | 0.1% | 131 |
|
|
2014
Q4 | $350K | Sell |
5,930
-174
| -3% | -$9.81K | 0.09% | 134 |
|
|
2014
Q3 | $312K | Sell |
6,104
-240
| -4% | -$12K | 0.08% | 138 |
|
|
2014
Q2 | $308K | Sell |
6,344
-1,001
| -14% | -$49.3K | 0.08% | 142 |
|
|
2014
Q1 | $382K | Buy |
7,345
+535
| +8% | +$28.5K | 0.1% | 128 |
|
|
2013
Q4 | $362K | Sell |
6,810
-5,517
| -45% | -$281K | 0.09% | 128 |
|
|
2013
Q3 | $570K | Buy |
12,327
+860
| +7% | +$37.8K | 0.16% | 105 |
|
|
2013
Q2 | $512K | Buy |
+11,467
| New | +$498K | 0.15% | 107 |
|
Other funds holding BMY
AIM
FWIA
DLA
ETC
Tompkins Financial's BMY Position: Q2 2026 in Review
Tompkins Financial reduced its Bristol-Myers Squibb (BMY) stake by 4.2% in Q2 2026, selling an estimated $11.5K and leaving 4,558 shares worth $263K. The position accounts for 0.02% of the portfolio, ranked #177.
Tompkins Financial first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.15M in Q2 2022. 851 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Tompkins Financial held 4,558 shares of Bristol-Myers Squibb worth $263K as of Q2 2026.
- Tompkins Financial sold 200 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.5K.
- Bristol-Myers Squibb made up 0.02% of Tompkins Financial's portfolio in Q2 2026, its #177 holding.
- Tompkins Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Tompkins Financial's Bristol-Myers Squibb position peaked at $1.15M in Q2 2022.
- 851 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Tompkins Financial's 13F filing for Q2 2026, filed 15 Jul 2026.